Eszopiclone cas no 138729 -47-2, eszopiclone,Wholesale, eszopiclone Suppliers, informations,dealers, traders, manufactures, products information, pharmaceuticals suppliers, active pharamaceuticals Taj Pharmaceuticals Ltd. (Taj Group)

Sitemap | Contact Us

Welcome To Taj Pharmaceuticals Ltd API

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved

Eszopiclone Taj Pharmaceuticals Ltd.

India

Latin America/ Caribbean

Africa & Middle East

Asia

Russia

Europe

Eszopiclone Manufacturers in India Suppliers Eszopiclone Dossage Exporters Distributors Eszopiclone api active pharmaceuticals ingredients Eszopiclone manufacturers Side Effects bulk drugs raw material Dossage Eszopiclone companies Side Effects Dossage Importers Eszopiclone Dossage Eszopiclone Exporters Eszopiclone exporters Dossage FDA Dossage Eszopiclone Dossage DMF Symptoms Dossage Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Eszopiclone manufacturing pharmaceutical drugs pharmaceutical intermediates Eszopiclone pharmaceutical chemicals pharmaceutical raw materials Eszopiclone active pharmaceutical ingredients Eszopiclone committee active pharmaceutical ingredients manufacturer Eszopiclone Active Pharmaceutical Ingredients manufacturer Eszopiclone exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Eszopiclone, Eszopiclone manufacturer India, Eszopiclone product, Eszopiclone products, Api preparation, Certificate of Analysis API manufacturer product, Eszopiclone anti ulcer product, Certificate of Origin COA Eszopiclone COS Eszopiclone, pharmaceutical generic, pharmaceutical drug, medical, Eszopiclone pharma healthcare, pharma patents, contract MSDS manufacturing Trader Eszopiclone pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Eszopiclone expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Eszopiclone DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Eszopiclone ingredients, api, HIV Eszopiclone, tablets, capsules, syrup & protein Eszopiclone powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Eszopiclone gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Eszopiclone WHO, UKMHRA Approval

	PRODUCT LIST
	Home
	API >>>
	Pharmaceuticals API List
	Chemicals
	Manufacturing
	Product Development
	Product Search
	Agro Chemicals
	Custom Pharma Services
	Contact Us

Molecular Structure Eszopiclone

HOME >> API >> API List1 >> Eszopiclone

CAS #: 138729-47-2,Eszopiclone,

Eszopiclone, Molecular Formula C17H17ClN6O3

Molecular Structure Eszopiclone
4-Methyl-1-piperazinecarboxylic acid 6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester,

CAS NO: 138729-47-2

Molecular Formula C17H17ClN6O3

Molecular Weight 388.81

CAS Registry Number 138729-47-2

4-Methyl-1-piperazinecarboxylic acid 6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester

Systematic (IUPAC) name
(5S)-6-(5-Chloro-2-pyridinyl)-7-oxo-

6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin -5-yl 4-methyl-1-piperazinecarboxylate

Chemical data

Formula C17H17ClN6O3
Mol. mass 388.808 g/mol
SMILES eMolecules & PubChem
Pharmacokinetic data
Bioavailability ?
Protein binding 52-59%
Metabolism Hepatic oxidation and demethylation (CYP3A4 and CYP2E1-mediated)
Half life 6 hours
Excretion Renal

Molecular Structure Eszopiclone,
4-Methyl-1-piperazinecarboxylic acid 6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester,

CAS NO: 138729-47-2

Molecular Formula C17H17ClN6O3

Molecular Weight 388.81

CAS Registry Number 138729-47-2

4-Methyl-1-piperazinecarboxylic acid 6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester

Systematic (IUPAC) name
(5S)-6-(5-Chloro-2-pyridinyl)-7-oxo-

6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin -5-yl 4-methyl-1-piperazinecarboxylate

Chemical data

Formula C17H17ClN6O3
Mol. mass 388.808 g/mol
SMILES eMolecules & PubChem
Pharmacokinetic data
Bioavailability ?
Protein binding 52-59%
Metabolism Hepatic oxidation and demethylation (CYP3A4 and CYP2E1-mediated)
Half life 6 hours
Excretion Renal

Information Associated with Product:

DRUG DESCRIPTION

DOSAGE

SIDE EFFECTS

PRECAUTIONS

INTERACTION

PHARMALOGY

CONSUMER INFORMATION

PDF DOWNLOAD

WORD DOCUMENT


Product Enquiry	Product Quotation	Sample Request	Place Your Order

Taj Pharmaceuticals API Logo

Api Manufacturing At Taj

Acamprosate Calcium	Clomipramine Hcl	Alendronate Sodium	Clonazepam	Amitriptyline	Clopidogrel Bisulfate	Anastrozole	Danazol	Atomoxetine Hcl	Desloratadine	Balsalazide
Desmopressin Monoacetate	Bicalutamide	Divalproex Sodium	Budesonide	Dobutamine Hcl	Bupropion Hcl	Donepezil	Calcitonin	Dothiepin Hcl	Capecitabine	Entacapone
Carbamazepine	Eptifibatide	Carboplatin	Escitalopram HBr	Carisoprodol	Eszopiclone	Carvedilol	Finasteride	Cefuroxime Axetil	Flurbiprofen	Cisplatin
Fluticasone Propionate	Citalopram Hbr	Fluvoxamine Maleate	Fosphenytoin Sodium

Investor Relations Feedback Contact Worldwide Sitemap

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.